Improving liver cancer care for HIV patients in Uganda
Leveraging HIV care infrastructure for implementation of context-adapted liver cancer comprehensive control strategies in Uganda: The LC3 Study
This study is looking to improve how we prevent and treat liver cancer for people living with HIV in Uganda by combining liver cancer care with their current HIV services, making it easier for patients to get the help they need.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11001696 on NIH RePORTER |
What this research studies
This research aims to enhance liver cancer control strategies by integrating them into existing HIV care services in Uganda. It focuses on understanding the co-infection of hepatitis B and HIV, and the resulting risks of liver cancer. The project will implement a comprehensive package of prevention, screening, and treatment interventions tailored to the local context, addressing barriers to care. By leveraging over 18 years of collaborative research, the study seeks to improve clinical management and outcomes for patients at risk of liver cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults living with HIV in Uganda, particularly those at risk for hepatitis B co-infection.
Not a fit: Patients who are not living with HIV or hepatitis B may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence and mortality of liver cancer among HIV patients in Uganda.
How similar studies have performed: Previous research has shown success in integrating hepatitis B services into HIV care, indicating a promising approach for this study.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Kirk, Gregory D — Johns Hopkins University
- Study coordinator: Kirk, Gregory D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.